U.S.

Trulieve Applauds Trump Administration Decision To Reschedule Marijuana to Schedule III

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., applauds action taken by the Trump Administration to reclassify marijuana to Schedule III under the Controlled Substances Act.

articleTrulieve Cannabis Corp.December 18, 20253/company/trulieve-cannabis-corp/news/trulieve-applauds-trump-administration-decision-190700192
Trulieve Applauds Trump Administration Decision To Reschedule Marijuana to Schedule III

About this update from Trulieve Cannabis Corp.

[{"type":"text","content":"Reclassification Eases Barriers to Research and Removes Punitive 280E Tax Burden ","length":80,"tagName":"p","attribs":{}},{"type":"text","content":"TALLAHASSEE, Fla., Dec. 18, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., applauds action taken by the Trump Administration to reclassify marijuana to Schedule III under the Controlled Substances Act.","length":351,"tagName":"p"},{"type":"image","alt":"Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)","displaySize":"","headline":null,"caption":"Trulieve logo (PRNewsfoto/Trulieve Cannabis Corp.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":257,"url":"https://media.zenfs.com/en/cnwgroup.com/7d6a1aaddff80bfd774237fb96448085"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/zx60UivjgPJ7cg0NcfCImQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ1MztjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/7d6a1aaddff80bfd774237fb96448085","width":400,"height":257}},"href":"https://mma.prnewswire.com/media/1720011/Trulieve_LogoV1.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""This bold and historic direction from President Trump represents long overdue change and a major milestone in cannabis reform," said Trulieve Chief Executive Officer Kim Rivers. "Trulieve is grateful for the decisive action taken by the Administration that acknowledges the medical benefits of cannabis, supports licensed and regulated operators, and allows law enforcement agencies to prosecute bad actors. We are committed to supporting the Administration throughout this process."","length":504,"tagName":"p"},{"type":"text","content":"Reclassification of marijuana to Schedule III does not legalize marijuana but it is an important first step in achieving practical common sense cannabis reform. Moving marijuana to Schedule III opens the door for more robust research of medical marijuana, removes the punitive tax burden imposed by Section 280E of the tax code, and retains flexibility for law enforcement to target and punish illicit operators.","length":412,"tagName":"p"},{"type":"text","content":"Eases Barriers to Conducting Critical Medical Marijuana Research Reclassifying marijuana to Schedule III ackn...

More updates from Trulieve Cannabis Corp.

cannabis reformmedical marijuanaPresident Trumpthe Trump AdministrationControlled Substances ActTrulieve